Study of a Drug Candidate, Mul-1867, for Inhalation Therapy of Fungal Pneumonia Caused by Clinical Isolates of Aspergillus fumigatus in a Murine Lung Infection Model

ASM Microbe 2017 (June 01-04, 2017, New Orleans, LA)

Study of a Drug Candidate, Mul-1867, for Inhalation Therapy of Fungal Pneumonia Caused by Clinical Isolates of Aspergillus fumigatus in a Murine Lung Infection Model